SciVision Biotech (Taiwan) Today
| 1786 Stock | TWD 92.20 0.30 0.33% |
Performance0 of 100
| Odds Of DistressLess than 9
|
SciVision Biotech is selling for under 92.20 as of the 4th of December 2024; that is 0.33 percent increase since the beginning of the trading day. The stock's lowest day price was 91.5. SciVision Biotech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for SciVision Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2024 and ending today, the 4th of December 2024. Click here to learn more.
SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. SciVision Biotech Inc.was founded in 2001 and is based in Kaohsiung, Taiwan. SCIVISION BIOTECH operates under Medical Instruments Supplies classification in Taiwan and is traded on Taiwan Stock Exchange.. The company has 66.19 M outstanding shares. More on SciVision Biotech
Moving together with SciVision Stock
Moving against SciVision Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
SciVision Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. SciVision Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding SciVision Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Medical Instruments & Supplies, Healthcare, Computing (View all Sectors) |
SciVision Biotech (1786) is traded on Taiwan Stock Exchange in Taiwan and employs 11 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.92 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SciVision Biotech's market, we take the total number of its shares issued and multiply it by SciVision Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. SciVision Biotech operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 66.19 M outstanding shares.
SciVision Biotech has accumulated about 508.81 M in cash with 98.51 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.76.
Check SciVision Biotech Probability Of Bankruptcy
Ownership AllocationSciVision Biotech shows a total of 66.19 Million outstanding shares. SciVision Biotech maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check SciVision Ownership Details
SciVision Biotech Risk Profiles
Although SciVision Biotech's alpha and beta are two of the key measurements used to evaluate SciVision Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.65 | |||
| Standard Deviation | 2.42 | |||
| Variance | 5.86 | |||
| Risk Adjusted Performance | (0.17) |
SciVision Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in SciVision Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Additional Tools for SciVision Stock Analysis
When running SciVision Biotech's price analysis, check to measure SciVision Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SciVision Biotech is operating at the current time. Most of SciVision Biotech's value examination focuses on studying past and present price action to predict the probability of SciVision Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SciVision Biotech's price. Additionally, you may evaluate how the addition of SciVision Biotech to your portfolios can decrease your overall portfolio volatility.